Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Györgyi Bökönyi"'
Autor:
Györgyi Bökönyi, Attila Varga, Krisztina Ludányi, György Kéri, Tibor Vántus, Pál Gyulavári, Domonkos Pap, József Murányi, Henriette Tanai, Gábor Mező
Publikováno v:
Journal of Peptide Science. 22:552-560
Targeted tumour therapy is the focus of recent cancer research. Gonadotropin-releasing hormone (GnRH) analogues are able to deliver anticancer agents selectively into tumour cells, which highly express GnRH receptors. However, the effectiveness of di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::02c3cc3cd3279c98b8c542d8612a7cb3
https://doi.org/10.1002/psc.2904
https://doi.org/10.1002/psc.2904
Autor:
József, Murányi, Pál, Gyulavári, Attila, Varga, Györgyi, Bökönyi, Henriette, Tanai, Tibor, Vántus, Domonkos, Pap, Krisztina, Ludányi, Gábor, Mező, György, Kéri
Publikováno v:
Journal of peptide science : an official publication of the European Peptide Society. 22(8)
Targeted tumour therapy is the focus of recent cancer research. Gonadotropin-releasing hormone (GnRH) analogues are able to deliver anticancer agents selectively into tumour cells, which highly express GnRH receptors. However, the effectiveness of di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::39db1591348b6d8f7dd694b9d66cb9ed
https://pubmed.ncbi.nlm.nih.gov/27443981
https://pubmed.ncbi.nlm.nih.gov/27443981
Publikováno v:
British Journal of Cancer
A novel somatostatin analogue, TT-232 (which inhibits the proliferation of various cell cultures and transplantable mouse tumours), was examined regarding its effect on human melanoma and lymphoma xenografts as a single treatment or in combination wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::decfb3a83d462bd651dbb41767b23cfe
https://doi.org/10.1038/sj.bjc.6600668
https://doi.org/10.1038/sj.bjc.6600668
Autor:
M. Idei, Edit Szabó, John M. Ostresh, György Kéri, Györgyi Bökönyi, Richard A. Houghten, Lászó Örfi, Ferenc Hollósy, Béla Szende, Istvan Teplan, Anikó Horváth
Publikováno v:
Journal of Peptide Science. 6:S191-S200
The aim of our work was to screen peptidomimetic tyrosine kinase inhibitory libraries for antiproliferative and apoptotic or necrotic effect. We also wanted to distinguish between cytostatic and cytotoxic activities.4-Benzylaminoquinasolines can be p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2f137007a59e050619e452ffe7c2859b
https://doi.org/10.1002/psc.21
https://doi.org/10.1002/psc.21
Autor:
Aniko Horvath, María J. Alonso, Yolanda Parajó, Györgyi Bökönyi, Ivana d'Angelo, Marcos Garcia-Fuentes, Tibor Vántus, György Kéri, Alexander Welle
New blood vessel formation is a critical requirement for treating many vascular and ischemia related diseases, as well as for many tissue engineering applications. Angiogenesis and vasculogenesis, in fact, represent crucial processes for the function
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b27f340c68a5394fc5ad9c05ca99bd9c
http://hdl.handle.net/11591/330609
http://hdl.handle.net/11591/330609
Autor:
György Kéri, Edit Várkondi, Györgyi Bökönyi, Ákos Pap, Eszter Schafer, Richard Schwab, István Peták, Tibor Gyökeres, Orsolya Szokolóczi, Laszlo Orfi
Publikováno v:
Journal of receptor and signal transduction research. 25(1)
Receptor tyrosine kinases (PTKs) play key roles in the pathogenesis of numerous human diseases, including cancer, and therefore PTK inhibitors are currently under intense investigation as potential drug candidates. PTK inhibitor screening data are, h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb5fc116dbf34002219a78aea9f9e997
https://pubmed.ncbi.nlm.nih.gov/15960394
https://pubmed.ncbi.nlm.nih.gov/15960394